[
    {
        "other_ids": [
            {
                "name": "Study Protocol Other Identifier",
                "value": "2019-003600-12"
            }
        ],
        "amendment_date": null,
        "keywords": [
            "Farletuzumab ecteribulin",
            "Neoplasms",
            "Endometrial Neoplasms",
            "Negative Breast Cancer",
            "Endometrial Carcinoma",
            "Carcinoma",
            "Non-Small-Cell Lung",
            "Adenocarcinoma",
            "Ovarian Neoplasms",
            "Folate Receptor Alpha (FRA)"
        ],
        "dcp_id": null,
        "interventional_model": "SEQUENTIAL_ASSIGNMENT",
        "lead_org": "Eisai Inc",
        "eligibility": {
            "unstructured": [
                {
                    "inclusion_indicator": true,
                    "display_order": 0,
                    "description": "Aged >=18 years"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 1,
                    "description": "For Dose-Escalation: Females (TNBC, EC and OC) or males/females (NSCLC, adenocarcinoma). Participants with the following disease characteristics: Participants with the following tumor types, each as a separate arm:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 2,
                    "description": "TNBC: Histologically confirmed diagnosis of metastatic TNBC (that is, estrogen receptor (ER) negative/progesterone receptor negative/ human epidermal growth factor receptor 2 (HER2) negative (defined as immunohistochemistry (IHC) less than (<) 2 plus (+) or fluorescence in situ hybridization (FISH) negative) breast cancer). Previously treated with at least one line of systemic anticancer therapy (cytotoxic or targeted anticancer agents) in the metastatic setting."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 3,
                    "description": "NSCLC adenocarcinoma: Histologically or cytologically confirmed metastatic NSCLC adenocarcinoma: participants who have failed previous treatment for metastatic disease, are not indicated or failed epidermal growth factor receptor (EGFR)-, Anaplastic lymphoma kinase (ALK) -, B-Raf proto-oncogene (BRAF) - or c-ros oncogene 1 (ROS1) - targeted therapy, and for whom no alternative standard therapy exists."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 4,
                    "description": "EC: Histologically confirmed diagnosis of advanced, recurrent or metastatic EC. Relapsed or failure of at least one platinum-based regimen or one immunotherapy-based regimen."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 5,
                    "description": "OC or primary peritoneal cancer or fallopian tube cancer: Histologically confirmed diagnosis of high grade serous epithelial ovarian cancer or primary peritoneal cancer or fallopian tube cancer. Participants must have:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 6,
                    "description": "platinum-resistant disease (defined as progression within 6 months after the last dose of at least 4 cycles of the last platinum containing chemotherapy regimen)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 7,
                    "description": "received up to 4 lines of systemic therapy post development of platinum resistance. For Dose-Confirmation: Ovarian cancer or primary peritoneal cancer or fallopian tube cancer:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 8,
                    "description": "Platinum-resistant disease:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 9,
                    "description": "For participant with 1 line of platinum-containing therapy: RECIST version 1.1 progression greater than (>) 1 month and less than or equal to (<=) 6 months after the last dose of the first platinum-containing chemotherapy regimen (of at least 4 cycles)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 10,
                    "description": "For participant with 2-3 lines of platinum-containing therapy: RECIST version 1.1 progression during or within 6 months after the last dose of the 2nd or 3rd platinum-containing chemotherapy regimen."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 11,
                    "description": "Have received up to 3 prior lines of systemic therapy and for whom single-agent therapy is appropriate as the next line of therapy. Participants may have been treated with up to one line of therapy subsequent to determination of platinum-resistance."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 12,
                    "description": "Neoadjuvant plus/minus (\u00b1) adjuvant will be considered 1 line of therapy."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 13,
                    "description": "Maintenance therapy (example, bevacizumab, PARP inhibitors) will be considered part of the preceding line of therapy (will not be counted as an independent line of therapy)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 14,
                    "description": "Hormonal therapy will be counted as a separate line of therapy unless it was given as maintenance."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 15,
                    "description": "Therapy changed due to toxicity in the absence of progression will be considered part of the same line."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 16,
                    "description": "Participants must have histologically confirmed diagnosis of advanced, recurrent, or metastatic EC. All histologic (including carcinosarcoma [no more than one participant at any dose level]) and molecular subtypes will be included. Participants may have been treated with an Immune Checkpoint Inhibitor (ICI) containing regimen (or be ineligible for ICI treatment) and must have had no more than 2 prior regimens (not including adjuvant therapy if progression or recurrent/metastatic disease occurred more than 6 months after the completion of the last cycle of adjuvant therapy)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 17,
                    "description": "Note: There is no restriction regarding prior hormonal therapy."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 18,
                    "description": "Available tumor tissue for FR\u03b1 expression percent (%) by IHC analysis as assessed by the vendor. There is no minimum requirement for FR\u03b1 expression (%). However, the tumor sample must be evaluable for IHC analysis (that is, of sufficient quality and quantity). Sample re-submission will be permitted for participants with tissue result of \"non-evaluable\" who are otherwise eligible. Tumor sample submission must be archival formalin-fixed, paraffin-embedded (FFPE) tissue block , or unstained slides sectioned within 45 days from the latest FFPE block, or a fresh biopsy sample obtained during screening but prior to initiation of study treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 19,
                    "description": "Radiological disease progression on or after the most recent therapy by investigator assessment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 20,
                    "description": "Measurable disease meeting the following criteria (confirmed by central radiographic review, in the Dose-Confirmation Part only):"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 21,
                    "description": "At least one lesion of >1.0 centimeter (cm) in long axis diameter for non-lymph nodes or >1.5 cm in short axis diameter for lymph nodes that is serially measurable according to Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 using either computed tomography (CT) or magnetic resonance imaging (MRI),"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 22,
                    "description": "Lesions that have had external beam radiotherapy (EBRT) or loco-regional therapies such as radiofrequency (RF) ablation must show evidence of PD based on RECIST 1.1 to be deemed a target lesion."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 23,
                    "description": "ECOG PS of 0 or 1."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 24,
                    "description": "Participants who are expected to survive a minimum of 3 months after the first administration of the study drug."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 25,
                    "description": "Adequate renal function as evidenced by serum creatinine less than or equal to (<=) 1.5 milligram per deciliter (mg/dL) or calculated creatinine clearance >=50 milliliter per (mL) /minute according to a 12 or 24 hour urine collection."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 26,
                    "description": "Adequate bone marrow function, as evidenced by:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 27,
                    "description": "Absolute neutrophil count (ANC) >=1.0*10^9 per liter (/L)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 28,
                    "description": "Hemoglobin (Hgb) >=9.0 gram per deciliter (g/dL)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 29,
                    "description": "Platelet count >=75*10^9/L Growth factors or transfusions as per institutional practice, are allowed if needed to achieve the above values. Growth factor and platelet transfusion should not be used within 7 days of initiation of study treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 30,
                    "description": "Adequate liver function, as evidenced by:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 31,
                    "description": "Total bilirubin <=1.5*upper limit of normal (ULN) except for unconjugated hyperbilirubinemia (example, Gilbert's syndrome)"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 32,
                    "description": "Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) <=3*ULN (in the case of liver metastases <=5*ULN) unless there are bone metastases. Participants with Alkaline Phosphatase (ALP) <=3*ULN unless they and are known to have bone metastases in which case higher ALP values will also be allowed."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 33,
                    "description": "Albumin >3.0 g/dL."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 34,
                    "description": "Participants must undergo a washout period required from the end of prior treatment to the first administration of the study drug that will be as follows: Prior anticancer therapy:"
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 35,
                    "description": "Prior chemotherapy, surgical therapy, radiation therapy: >3 weeks. Prior chest radiotherapy or pneumonectomy is an exclusion."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 36,
                    "description": "Antibody and other biologic therapeutic agents: >=4 weeks."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 37,
                    "description": "Endocrine therapy or, small-molecule targeted therapy: >2 weeks."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 38,
                    "description": "Immunotherapy >=4 weeks."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 39,
                    "description": "Participants with a history of deep vein thrombosis (DVT) within 3 months prior must have completed at least 1 month of anticoagulation prior to starting study treatment. Anticoagulation must continue while on study treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 40,
                    "description": "Participants at risk for DVT secondary to central venous catheters or with past medical history of DVT or clinical symptoms suggestive of DVT must have venous Doppler ultrasonography to rule out DVT during the screening period and prior to initiation of study treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 41,
                    "description": "If a participant has undergone major surgery, the participant must have recovered adequately from the toxicity and/or complications from the intervention prior to starting study treatment."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 42,
                    "description": "Resolution of anticancer therapy-related or radiation-related toxicities to Grade 1 severity or lower, except for stable sensory neuropathy (Grade <=2), anemia ([haemoglobin] Hgb >=9.0 g/dL), and alopecia (any grade)."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 43,
                    "description": "Participant must be willing and able to comply with all aspects of the protocol."
                },
                {
                    "inclusion_indicator": true,
                    "display_order": 44,
                    "description": "Participant must provide written informed consent prior to any study-specific screening procedures."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 45,
                    "description": "Participants with endometrial leiomyosarcoma, endometrial stromal sarcoma or high-grade sarcoma."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 46,
                    "description": "Participants who received previous treatment with any folate receptor targeting agents."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 47,
                    "description": "Participants with platinum refractory ovarian cancer (defined as disease progression during the initial platinum-based chemotherapy treatment)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 48,
                    "description": "Currently enrolled in another clinical study or used any investigational drug or device, which in the opinion of the Sponsor may interfere with the study treatment, within the past 28 days or 5 times the half-life (where prior drug therapy falls under the parameters these Inclusion Criteria should be followed) of any investigational drug preceding informed consent."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 49,
                    "description": "Participants with brain or subdural metastases are not eligible, unless they have completed local therapy and have discontinued the use of corticosteroids for this indication for at least 2 weeks before starting treatment in this study. Any signs (example, radiologic) or symptoms of brain metastases must be stable for at least 4 weeks before starting study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 50,
                    "description": "Diagnosed with meningeal carcinomatosis."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 51,
                    "description": "Any other invasive malignancy that required treatment (other than definitive surgery) or has shown evidence of recurrence/progression (except for non-melanoma skin cancer, or histologically confirmed complete excision of carcinoma in situ) during the 2 years prior to starting study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 52,
                    "description": "Significant cardiovascular impairment. History within 6 months prior to the first dose of study drug of: congestive heart failure greater than New York Heart Association (NYHA) Class II); unstable angina; myocardial infarction; stroke; cardiac arrhythmia associated with hemodynamic instability."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 53,
                    "description": "Clinically significant ECG abnormality, including marked prolonged baseline QT as corrected using Fridericia's formula (QTcF) (repeated demonstration of a QTcF interval >500 milliseconds [ms]). A history of risk factors for torsade de pointes (example, heart failure, hypokalemia, family history of long QT Syndrome) or the use of concomitant medications that prolong the QTcF."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 54,
                    "description": "Known to be Human Immunodeficiency Virus (HIV) positive. Testing at entry not required."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 55,
                    "description": "Active viral hepatitis (B or C as demonstrated by positive serology). Testing at entry if there are no symptoms or history is not required unless as per local requirements."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 56,
                    "description": "Females who are breastfeeding or pregnant at Screening or Baseline (as documented by a positive beta human chorionic gonadotropin [\u00df-hCG] or human chorionic gonadotropin [hCG]) with a minimum sensitivity of 25 International units per liter (IU/L) or equivalent units of \u00df-hCG [or hCG]. A separate baseline assessment is required if a negative screening pregnancy test was obtained more than 72 hours before the first administration of the study drug."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 57,
                    "description": "Females of childbearing potential who"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 58,
                    "description": "within 28 days before study entry, did not use a highly effective method of contraception, which includes any of the following:"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 59,
                    "description": "total abstinence (if it is their preferred and usual lifestyle)*"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 60,
                    "description": "an intrauterine device or intrauterine hormone-releasing system (IUS)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 61,
                    "description": "a contraceptive implant"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 62,
                    "description": "an oral contraceptive (participant must be on a stable dose of the same oral contraceptive product for at least 28 days before dosing and throughout the study and for 90 days after study drug discontinuation)"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 63,
                    "description": "have a vasectomized partner with confirmed azoospermia"
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 64,
                    "description": "do not agree to use a highly effective method of contraception (as described above) throughout the entire study period and for 90 days after study drug discontinuation. For sites outside of the EU, it is permissible that if a highly effective method of contraception is not appropriate or acceptable to the participant, then the participant must agree to use a medically acceptable method of contraception, that is, double-barrier methods of contraception such as latex or synthetic condom plus diaphragm or cervical/vault cap with spermicide. NOTE: All females will be considered to be of childbearing potential unless they are postmenopausal (amenorrheic for at least 12 consecutive months, in the appropriate age group, and without other known or suspected cause) or have been sterilized surgically (that is, bilateral tubal ligation, total hysterectomy, or bilateral oophorectomy, all with surgery at least 1 month before dosing). *Sexual abstinence is considered a highly effective method only if defined as refraining from heterosexual intercourse during the entire period of risk associated with the study intervention. The reliability of sexual abstinence needs to be evaluated in relation to the duration of the study and the preferred and usual lifestyle of the participant."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 65,
                    "description": "For Dose-Escalation only: Males who have not had a successful vasectomy (confirmed azoospermia) or they and their female partners do not meet the criteria above (that is, not of childbearing potential or practicing highly effective contraception throughout the study period and for 90 days after study drug discontinuation). If the female partner is pregnant, then males who do not agree to use latex or synthetic condoms throughout the study period and for 90 days after study drug discontinuation. No sperm donation is allowed during the study period and for 90 days after study drug discontinuation."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 66,
                    "description": "Pulmonary Function Test (PFT) abnormalities: FEV1/FVC <0.7, FEV1 or FVC <80%, DLCO <80%."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 67,
                    "description": "Current ILD/pneumonitis, or ILD/pneumonitis is suspected at Screening or history of interstitial lung disease (ILD)/pneumonitis of any severity including ILD/pneumonitis from prior anticancer therapy."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 68,
                    "description": "Current infectious pneumonia, history of viral pneumonia (including COVID-19-related infection) with evidence of persistent radiologic abnormalities."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 69,
                    "description": "Lung-specific clinically significant illnesses including, but not limited to any underlying pulmonary disorder (example, pulmonary embolism), asthma, chronic obstructive pulmonary disease (COPD), and restrictive lung disease."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 70,
                    "description": "Clinically significant pleural or pericardial effusion requiring drainage or ascites requiring peritoneal shunt."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 71,
                    "description": "Prior pneumonectomy."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 72,
                    "description": "History of chest radiotherapy. Participants with history of chest wall radiation (example, history of breast cancer) may be permitted if chest wall radiation is documented > 2 years before starting study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 73,
                    "description": "Any autoimmune, connective tissue, or inflammatory disorders (example, rheumatoid arthritis, Sj\u00f6gren's syndrome, sarcoidosis, etc) where there is documented (or suspicion of) pulmonary involvement."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 74,
                    "description": "A known history of active TB (bacillus tuberculosis)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 75,
                    "description": "Scheduled for surgery during the study, other than minor surgery which would not delay study treatment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 76,
                    "description": "An active clinically significant (in the opinion of the Investigator) infection requiring systemic therapy within 2 weeks prior to the first dose of study drug."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 77,
                    "description": "Administration of a live, attenuated vaccine within 4 weeks prior to the first dose of study drug, or anticipation that such a live attenuated vaccine will be required during the study. Inactivated vaccines (such as hepatitis A or polio vaccines) are permitted during the study. Seasonal influenza and COVID-19 vaccines that do not contain live virus are permitted."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 78,
                    "description": "Any prior hypersensitivity to monoclonal antibodies or contraindication to the receipt of corticosteroids or any of the excipients (investigators should refer to the prescribing information for the selected corticosteroid)."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 79,
                    "description": "Known intolerance to either of the components of the study drug."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 80,
                    "description": "Any medical or other condition which, in the opinion of the investigator would preclude the participants participation in the clinical study."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 81,
                    "description": "Receiving any medication prohibited in combination with the study treatment(s) as described in the product label for eribulin, unless medication was stopped within 7 days prior to enrollment."
                },
                {
                    "inclusion_indicator": false,
                    "display_order": 82,
                    "description": "Known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial."
                }
            ],
            "structured": {
                "max_age": "999 Years",
                "max_age_number": 999.0,
                "min_age_unit": "Years",
                "max_age_unit": "Years",
                "max_age_in_years": 999.0,
                "gender": "BOTH",
                "accepts_healthy_volunteers": false,
                "min_age": "18 Years",
                "min_age_number": 18.0,
                "min_age_in_years": 18.0
            }
        },
        "completion_date_type_code": "ANTICIPATED",
        "detail_description": null,
        "official_title": "A Multicenter, Open-Label Phase 1/2 Trial Evaluating the Safety, Tolerability, and Efficacy of MORAb-202, a Folate Receptor Alpha (FR\u03b1)-Targeting Antibody-drug Conjugate (ADC) in Subjects With Selected Tumor Types",
        "_phase_sort_order": 3,
        "collaborators": [],
        "associated_studies": [],
        "outcome_measures": [
            {
                "timeframe": "Baseline, up to approximately 4 years 8 months",
                "name": "Change From Baseline in Eastern Cooperative Oncology Group Performance Status (ECOG PS)",
                "description": "ECOG PS is used by doctors and researchers to assess how a participant's disease is progressing, assess how the disease affects the daily living activities of the participant and determine appropriate treatment and prognosis. ECOG has 6 levels (0 to 5). 0=Fully Active (Most Favorable Activity); 1=Restricted activity but ambulatory; 2=Ambulatory but unable to carry out work activities; 3=Limited Self-Care; 4=Completely Disabled, No self-care (Least Favorable Activity); 5=Dead.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to 28 days after the last dose of study drug (up to approximately 4 years 8 months)",
                "name": "Change From Baseline in Oxygen Saturation (SpO2)",
                "description": "Change from baseline in percent of SpO2 (measured by pulse oximetry) will be calculated by measuring oxygen saturation at rest and immediately after exercise.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From first dose of study drug until disease progression or death, whichever occurs first (up to approximately 4 years 8 months)",
                "name": "Clinical Benefit Rate (CBR)",
                "description": "CBR is defined as the percentage of participants with BOR of CR, PR, or durable SD (duration of SD greater than or equal to [>=] 23 weeks). Duration of SD is defined as the time from the date of first dose to the date of the first documentation of disease progression or death, whichever occurs first. It will be calculated for participants whose BOR is SD. CBR will be assessed according to RECIST version 1.1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From first dose of study drug until first documentation of CR or PR or SD (up to approximately 4 years 8 months)",
                "name": "Disease Control Rate (DCR)",
                "description": "DCR is defined as the percentage of participants with BOR of CR, PR, or stable disease (SD). DCR will be assessed according to RECIST version 1.1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Cycle 1 (Cycle length is equal to [=] 21 days)",
                "name": "Dose Escalation Part: Recommended Phase 2 Dose (RP2D) of Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From first documented CR or PR until first documentation of recurrent or progressive disease or death (up to approximately 4 years 8 months)",
                "name": "Duration of Response (DOR)",
                "description": "DOR is defined as the time from the first date of documented CR or PR to the date of disease progression or death, whichever occurs first. It will be calculated for participants whose BOR is CR or PR. DOR will be assessed according to RECIST version 1.1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to 28 days after the last dose of study drug (up to approximately 2 years 7 months)",
                "name": "Investigate tumor Folate Receptor Alpha (FRA) expression levels association with and predictive power for clinical outcomes (objective response and progression free survival)",
                "description": "Evaluate how clinical outcomes like objective response and progression free survival correlate with the level of expression of FRA in tumors.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Baseline up to 28 days after the last dose of study drug (up to approximately 4 years 8 months)",
                "name": "Number of Participants With Clinically Significant Change From Baseline in Clinical Laboratory Values, Vital Signs, Body Weight and 12-lead Electrocardiograms",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Cycle 1 (Cycle length=21 days)",
                "name": "Number of Participants With Dose-limiting Toxicities (DLTs)",
                "description": "DLTs are any of the toxicities occurring during Cycle 1 and assessed by the investigator as related to study drug. Toxicity will be evaluated according to National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0 (NCI CTCAE 5.0).",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Baseline up to 28 days after the last dose of study drug (up to approximately 4 years 8 months)",
                "name": "Number of Participants With Serious Adverse Events (SAEs), Adverse Events (AEs) Leading to Treatment Discontinuation and Adverse Events of Interest (AEIs)",
                "description": "AE: as any untoward medical occurrence in a participant administered with an investigational product. SAE: as any untoward medical occurrence that at any dose; resulted in death, was life-threatening, required inpatient hospitalization or prolongation of existing hospitalization, resulted in persistent or significant disability/incapacity, or resulted incongenital anomaly/birth defect. AEIs are AEs that may be associated with the use of immunomodulatory drugs, such as infections, malignancies, autoimmune disorders, and injection reactions. Number of participants with AEIs were reported based on safety assessment of participants with interstitial lung disease (ILD), severity of ILD, time to resolution and onset of ILD symptoms and deaths due to ILD.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "Cycles (1-6) Day 1: pre-infusion and off treatment visit, within 28 days of last dose of study drug (up to approximately 4 years 8 months) (Cycle length=21 days)",
                "name": "Number of Participants With Serum Anti-Drug Antibodies (ADA) Titer to Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From date of first dose of study drug until first documentation of CR or PR (up to approximately 24 weeks)",
                "name": "Objective Response Rate (ORR)",
                "description": "ORR is defined as the percentage of participants with a best overall response (BOR) of complete response (CR) or partial response (PR), based on the investigator assessment of radiologic response according to Response Evaluation Criteria In Solid Tumors (RECIST) version 1.1.",
                "type_code": "PRIMARY"
            },
            {
                "timeframe": "From first dose of study drug until death (up to approximately 4 years 8 months)",
                "name": "Overall Survival (OS)",
                "description": "OS is defined as the time from the date of first dose to the date of death. For the participants who are alive or lost to follow up, OS is censored as the date of last known alive date or the date of data cutoff, whichever comes first. OS will be calculated using the Kaplan-Meier method.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Pre-infusion to 336 hours post-infusion",
                "name": "Pharmacokinetics (PK) Profiles: Maximum Observed Serum Concentration (Cmax) for Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Pre-infusion to 336 hours post-infusion",
                "name": "PK Profiles: Area Under the Serum Concentration-time Curve From 0 to Infinity (AUC[0-\u221e]) for Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Pre-infusion to 336 hours post-infusion",
                "name": "PK Profiles: Terminal Elimination Phase Half-life (t\u00bd) for Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Pre-infusion to 336 hours post-infusion",
                "name": "PK Profiles: Time of Cmax (tmax) for Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "From first dose of study drug until disease progression, death, whichever occurs first (up to approximately 4 years 8 months)",
                "name": "Progression Free Survival (PFS)",
                "description": "PFS is defined as the time from the date of first dose to the date of the first documentation of disease progression or death, whichever occurs first. PFS will be assessed according to RECIST version 1.1.",
                "type_code": "SECONDARY"
            },
            {
                "timeframe": "Cycles (1-6) Day 1: pre-infusion up to 336 hours post-infusion and off treatment visit (within 28 days of last dose of study drug) (Cycle length=21 days)",
                "name": "Total Antibody Concentration for Eribulin and Farletuzumab Ecteribulin",
                "description": null,
                "type_code": "SECONDARY"
            }
        ],
        "phase": "I_II",
        "central_contact": {
            "phone": null,
            "name": null,
            "type": null,
            "email": null
        },
        "primary_purpose": "TREATMENT",
        "number_of_arms": 3,
        "_study_protocol_type_sort_order": 0,
        "nct_id": "NCT04300556",
        "biomarkers": [
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Negative"
                ],
                "nci_thesaurus_concept_id": "C35681",
                "name": "Negative Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "FOLR2",
                    "Folate Receptor 2 (Fetal) Gene"
                ],
                "nci_thesaurus_concept_id": "C104913",
                "name": "FOLR2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612"
                ],
                "parents": [
                    "C20103"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER Alpha Status",
                    "ER Status",
                    "ER-Alpha Status",
                    "ERA Status",
                    "ESR Status",
                    "ESR1 Status",
                    "ESRA Status",
                    "ESTRR Status",
                    "Estrogen Receptor",
                    "Estrogen Receptor 1 Status",
                    "Estrogen Receptor Alpha Status",
                    "NR3A1 Status",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Status"
                ],
                "nci_thesaurus_concept_id": "C16150",
                "name": "Estrogen Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C38349",
                    "C94299",
                    "C54362",
                    "C188928",
                    "C20709",
                    "C21295",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C94299",
                "name": "Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C36292",
                    "C3367"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Expressed",
                    "Expression Detected"
                ],
                "nci_thesaurus_concept_id": "C177692",
                "name": "Expression Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35682",
                    "C36292"
                ],
                "parents": [
                    "C35682"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER-Negative PR-Negative ERBB2-Negative",
                    "ER-PR-HER2/neu-",
                    "ER-negative PR-negative HER2/neu-negative",
                    "ER/PR/HER2 Negative",
                    "ESR1/PGR/ERBB2 Negative Finding",
                    "Triple Negative Breast Cancer Finding",
                    "Triple Negative Breast Cancer Result",
                    "Triple-Negative Breast Cancer Result",
                    "triple-negative breast cancer"
                ],
                "nci_thesaurus_concept_id": "C71428",
                "name": "Triple-Negative Breast Cancer Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C35681",
                    "C21281",
                    "C20420",
                    "C3367",
                    "C36292",
                    "C16612",
                    "C38349",
                    "C28656",
                    "C94299",
                    "C21295",
                    "C20103",
                    "C165233",
                    "C25872",
                    "C20709",
                    "C17756",
                    "C54362",
                    "C20719",
                    "C77140",
                    "C25871",
                    "C25870"
                ],
                "parents": [
                    "C165233",
                    "C17756",
                    "C28656",
                    "C38349",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Positive",
                    "positive test result"
                ],
                "nci_thesaurus_concept_id": "C35682",
                "name": "Positive Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C36292"
                ],
                "parents": [
                    "C36292"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ER Alpha Negative",
                    "ER Negative",
                    "ER-",
                    "ER-Alpha Negative",
                    "ERA Negative",
                    "ESR Negative",
                    "ESR1 Negative",
                    "ESRA Negative",
                    "ESTRR Negative",
                    "Estrogen Receptor 1 Negative",
                    "Estrogen Receptor Alpha Negative",
                    "NR3A1 Negative",
                    "Negative",
                    "Negative Estrogen Receptor",
                    "Nuclear Receptor Subfamily 3 Group A Member 1 Negative"
                ],
                "nci_thesaurus_concept_id": "C15493",
                "name": "Estrogen Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C165744",
                    "C21295",
                    "C35681",
                    "C77140",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C38349",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16150"
                ],
                "parents": [
                    "C16150",
                    "C165744",
                    "C38349"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21295",
                "name": "Ligand Binding Protein Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25872",
                "name": "Kinase Family Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C25871",
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25871"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Observable Entity"
                ],
                "nci_thesaurus_concept_id": "C3367",
                "name": "Finding",
                "semantic_types": [
                    "Finding"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25870",
                "name": "Transferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612"
                ],
                "parents": [
                    "C21281"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C54362",
                "name": "Transcription Regulation Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20103",
                "name": "Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612",
                    "C21295"
                ],
                "parents": [
                    "C21295"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C21281",
                "name": "Enzyme Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C16612"
                ],
                "parents": [
                    "C16612"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Proto-Oncogene, Transcription Factor"
                ],
                "nci_thesaurus_concept_id": "C20420",
                "name": "Transcription Factor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C54362",
                    "C16612"
                ],
                "parents": [
                    "C54362"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Genes"
                ],
                "nci_thesaurus_concept_id": "C16612",
                "name": "Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "branch"
                ],
                "ancestors": [],
                "parents": [],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20719",
                "name": "Receptor Tyrosine Kinase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C16612",
                    "C20103",
                    "C25872",
                    "C25871",
                    "C25870",
                    "C21295"
                ],
                "parents": [
                    "C20103",
                    "C25872"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2",
                    "Erb-b2 Receptor Tyrosine Kinase 2 Gene",
                    "HER2",
                    "HER2/Neu",
                    "NEU"
                ],
                "nci_thesaurus_concept_id": "C17756",
                "name": "ERBB2 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C20719",
                    "C21295",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C25872",
                    "C25870"
                ],
                "parents": [
                    "C20719"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165744",
                "name": "Hormone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C35681",
                    "C77140",
                    "C3367",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C165233",
                    "C188928"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Absent",
                    "LOST",
                    "Loss of Expression",
                    "Negative",
                    "Not Expressed"
                ],
                "nci_thesaurus_concept_id": "C165233",
                "name": "Expression Negative",
                "semantic_types": [
                    "Cell or Molecular Dysfunction"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C3367",
                    "C35681"
                ],
                "parents": [
                    "C35681"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C25871",
                "name": "Phosphotransferase Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21281",
                    "C25870",
                    "C16612"
                ],
                "parents": [
                    "C25870"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "Negative",
                    "PGR Negative",
                    "PR Negative",
                    "PR-"
                ],
                "nci_thesaurus_concept_id": "C15497",
                "name": "Progesterone Receptor Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C165744",
                    "C21295",
                    "C28656",
                    "C35681",
                    "C77140",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292",
                    "C16149"
                ],
                "parents": [
                    "C16149",
                    "C165744",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ER",
                    "ESR1",
                    "Estrogen Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C38349",
                "name": "ESR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "FBP Positive",
                    "FOLR Positive",
                    "FOLR1 Positive",
                    "FR-Alpha Positive",
                    "Folate Receptor 1 Positive",
                    "Folate-Binding Protein, Adult Positive"
                ],
                "nci_thesaurus_concept_id": "C131327",
                "name": "Folate Receptor Alpha Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C77140",
                    "C16612",
                    "C104913",
                    "C94299",
                    "C21295",
                    "C20103",
                    "C153242",
                    "C3367",
                    "C35682",
                    "C36292",
                    "C177692",
                    "C39283"
                ],
                "parents": [
                    "C153242",
                    "C39283"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "LAB_RESULT",
                    "Lab Findings",
                    "Lab Value",
                    "Laboratory Finding",
                    "Laboratory Report",
                    "Labs",
                    "Test Result",
                    "test_result"
                ],
                "nci_thesaurus_concept_id": "C36292",
                "name": "Laboratory Test Result",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140"
                ],
                "parents": [
                    "C77140"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PgR Status",
                    "Progesterone Receptor"
                ],
                "nci_thesaurus_concept_id": "C16149",
                "name": "Progesterone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C21295",
                    "C28656",
                    "C77140",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C3367",
                    "C20709",
                    "C54362",
                    "C188928",
                    "C36292"
                ],
                "parents": [
                    "C188928",
                    "C28656"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "ERBB2 Status",
                    "Her2/Neu Value"
                ],
                "nci_thesaurus_concept_id": "C16152",
                "name": "HER2/Neu Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C94299",
                    "C20719",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C17756",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Folate Binding Protein Positive",
                    "Folate Receptor Positive",
                    "Folate-Binding Protein Positive"
                ],
                "nci_thesaurus_concept_id": "C153242",
                "name": "Folate Receptor Family Positive",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C177692",
                    "C94299",
                    "C104913",
                    "C35682",
                    "C39283",
                    "C36292",
                    "C21295",
                    "C16612",
                    "C77140",
                    "C3367",
                    "C20103"
                ],
                "parents": [
                    "C104913",
                    "C177692",
                    "C39283",
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "FOLR1",
                    "Folate Receptor 1 Gene"
                ],
                "nci_thesaurus_concept_id": "C39283",
                "name": "FOLR1 Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612"
                ],
                "parents": [
                    "C20103"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "Diagnostic Test Result",
                    "Test Result"
                ],
                "nci_thesaurus_concept_id": "C77140",
                "name": "Clinical Test Result",
                "semantic_types": [
                    "Finding"
                ],
                "type": [],
                "ancestors": [
                    "C3367"
                ],
                "parents": [
                    "C3367"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [],
                "nci_thesaurus_concept_id": "C20709",
                "name": "Nuclear Receptor Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [],
                "ancestors": [
                    "C21295",
                    "C20103",
                    "C16612",
                    "C20420",
                    "C54362"
                ],
                "parents": [
                    "C20103",
                    "C20420"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "HR Status"
                ],
                "nci_thesaurus_concept_id": "C188928",
                "name": "Hormone Receptor Status",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C3367",
                    "C77140",
                    "C36292",
                    "C94299"
                ],
                "parents": [
                    "C94299"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TRIAL",
                "synonyms": [
                    "ERBB2 Negative",
                    "HER-2 Negative",
                    "HER2 Negative"
                ],
                "nci_thesaurus_concept_id": "C68749",
                "name": "HER2/Neu Negative",
                "semantic_types": [
                    "Laboratory or Test Result"
                ],
                "type": [],
                "ancestors": [
                    "C165233",
                    "C94299",
                    "C20719",
                    "C35681",
                    "C21295",
                    "C77140",
                    "C21281",
                    "C20103",
                    "C16612",
                    "C25871",
                    "C16152",
                    "C3367",
                    "C25872",
                    "C17756",
                    "C25870",
                    "C36292"
                ],
                "parents": [
                    "C16152",
                    "C165233",
                    "C17756"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            },
            {
                "eligibility_criterion": "inclusion",
                "inclusion_indicator": "TREE",
                "synonyms": [
                    "PGR",
                    "PR",
                    "Progesterone Receptor Gene"
                ],
                "nci_thesaurus_concept_id": "C28656",
                "name": "PGR Gene",
                "semantic_types": [
                    "Gene or Genome"
                ],
                "type": [
                    "reference_gene"
                ],
                "ancestors": [
                    "C21295",
                    "C16612",
                    "C20103",
                    "C20420",
                    "C20709",
                    "C54362"
                ],
                "parents": [
                    "C20709"
                ],
                "assay_purpose": "Eligibility Criterion - Inclusion"
            }
        ],
        "classification_code": null,
        "current_trial_status_date": "2022-04-19",
        "diseases": [
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian High-Grade Serous Adenocarcinoma",
                    "Ovarian High Grade Serous Adenocarcinoma",
                    "High-Grade Ovarian Serous Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C105555",
                "name": "High Grade Ovarian Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7550"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Primary Peritoneal High-Grade Serous Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C126353",
                "name": "Primary Peritoneal High Grade Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C40023"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube High-Grade Serous Adenocarcinoma",
                    "High Grade Fallopian Tube Serous Carcinoma",
                    "Fallopian Tube High Grade Serous Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C126456",
                "name": "High Grade Fallopian Tube Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C40099"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": true,
                "synonyms": [
                    "Malignant Solid Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C132146",
                "name": "Malignant Solid Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9292",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV",
                    "Stage IV Lung Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C136482",
                "name": "Stage IV Lung Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C136467"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Anatomic Stage IV Breast Carcinoma AJCC v8",
                    "Anatomic Stage IV Breast Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139545",
                "name": "Stage IV Breast Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139533"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage III Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8",
                    "Stage III",
                    "Stage III Uterine Corpus Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139806",
                "name": "Stage III Uterine (including Endometrial) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139801"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Stage IV Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8",
                    "Stage IV",
                    "Stage IV Uterine Corpus Cancer AJCC v8"
                ],
                "nci_thesaurus_concept_id": "C139812",
                "name": "Stage IV Uterine (including Endometrial) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139801"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Platinum-Resistant Ovarian Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C147561",
                "name": "Platinum-Resistant Ovarian Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C150091",
                    "C169021"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150094",
                "name": "Recurrent Endometrial Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C9072",
                    "C7558",
                    "C7620"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153348",
                "name": "Metastatic Triple-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C71732",
                    "C190677"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156068",
                "name": "Metastatic Endometrial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C162254",
                    "C146893",
                    "C7558"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156094",
                "name": "Metastatic Lung Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2926",
                    "C165537",
                    "C153202"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Platinum-Resistant Fallopian Tube Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C157621",
                "name": "Platinum-Resistant Fallopian Tube Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C152047",
                    "C169021"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Platinum-Resistant Primary Peritoneal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C157622",
                "name": "Platinum-Resistant Primary Peritoneal Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C152046"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C159676",
                "name": "Advanced Endometrial Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156068",
                    "C164143",
                    "C172450"
                ]
            },
            {
                "inclusion_indicator": "TRIAL",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of Lung",
                    "Adenocarcinoma",
                    "Adenocarcinoma of the Lung",
                    "LUAD"
                ],
                "nci_thesaurus_concept_id": "C3512",
                "name": "Lung Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27745",
                    "C2926"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Solid Neoplasm",
                    "Solid Tumour",
                    "Solid tumor, NOS"
                ],
                "nci_thesaurus_concept_id": "C9292",
                "name": "Solid Tumor",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "disease term",
                    "Diseases",
                    "Disease",
                    "Diseases and Disorders",
                    "disease_term",
                    "Diagnosis",
                    "Disease or Disorder, Non-Neoplastic",
                    "disease type",
                    "Disorders",
                    "Disease or Disorder",
                    "Disorder",
                    "condition",
                    "disease_type"
                ],
                "nci_thesaurus_concept_id": "C2991",
                "name": "Other Disease",
                "type": [
                    "maintype"
                ],
                "parents": []
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7062",
                "name": "Neoplasm by Special Category",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm",
                    "Neoplasms, NOS",
                    "tumor",
                    "Neoplastic Growth",
                    "Tumor, NOS",
                    "Neoplasia",
                    "Neoplasm, NOS",
                    "Neoplastic Disease"
                ],
                "nci_thesaurus_concept_id": "C3262",
                "name": "Other Neoplasm",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": true,
                "synonyms": [
                    "Neoplasm, malignant",
                    "Cancer",
                    "Tumor, malignant, NOS",
                    "Malignancy",
                    "Unclassified tumor, malignant",
                    "Malignant Neoplastic Disease",
                    "Malignant Growth",
                    "CA",
                    "Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C9305",
                "name": "Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Thorax",
                    "Malignant Neoplasm of Thorax",
                    "Malignant Thoracic Tumor",
                    "Malignant Tumor of the Thorax",
                    "Malignant Neoplasm of the Thorax"
                ],
                "nci_thesaurus_concept_id": "C3576",
                "name": "Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C3406"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C27815",
                "name": "Malignant Endometrial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3556",
                    "C3012"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Anatomic Stage"
                ],
                "nci_thesaurus_concept_id": "C139533",
                "name": "Breast Cancer by AJCC v8 Anatomic Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C139532"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170733",
                "name": "Primary Peritoneal Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C40022",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153171",
                "name": "Advanced Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Tumor"
                ],
                "nci_thesaurus_concept_id": "C7628",
                "name": "Refractory Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Respiratory, Thoracic, and Mediastinal Disorder",
                    "Respiratory and Thoracic Disease",
                    "Respiratory, Thoracic, and Mediastinal Disease"
                ],
                "nci_thesaurus_concept_id": "C27669",
                "name": "Respiratory and Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal and Retroperitoneal Tumor"
                ],
                "nci_thesaurus_concept_id": "C7337",
                "name": "Peritoneal and Retroperitoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C27664"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176859",
                "name": "Advanced Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9270",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of Fallopian Tube",
                    "Neoplasm of the Fallopian Tube",
                    "Tumor of Fallopian Tube",
                    "Fallopian Tube Tumor",
                    "Tumor of the Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C3032",
                "name": "Fallopian Tube Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26771",
                    "C3053"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Carcinoma by AJCC v8 Stage"
                ],
                "nci_thesaurus_concept_id": "C139532",
                "name": "Breast Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal and Retroperitoneal Disease"
                ],
                "nci_thesaurus_concept_id": "C27664",
                "name": "Peritoneal and Retroperitoneal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Triple-Negative Breast Carcinoma",
                    "Triple Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C71732",
                "name": "Triple-Negative Breast Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C53553",
                    "C165743"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of the Reproductive System",
                    "Reproductive Neoplasm",
                    "Reproductive System Tumor",
                    "Neoplasm of Reproductive System",
                    "Reproductive Tumor",
                    "Tumor of Reproductive System",
                    "Tumor of the Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C3674",
                "name": "Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Advanced Cancer"
                ],
                "nci_thesaurus_concept_id": "C9270",
                "name": "Advanced Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Nonsmall Cell Adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C27745",
                "name": "Non-Small Cell Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C65151"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Gynecological Disorder",
                    "Female Reproductive System Disease"
                ],
                "nci_thesaurus_concept_id": "C27020",
                "name": "Female Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4875"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153202",
                "name": "Metastatic Lung Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C176862",
                    "C4878",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm, Fallopian Tube, Malignant",
                    "Malignant Fallopian Tube Tumor",
                    "Fallopian Tube Malignant Neoplasm",
                    "Fallopian Tube Malignant Tumor",
                    "Malignant Neoplasm of the Fallopian Tube",
                    "Malignant Tumor of the Fallopian Tube",
                    "Malignant Neoplasm of Fallopian Tube",
                    "Tumor, Fallopian Tube, Malignant",
                    "Malignant Tumor of Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C7480",
                "name": "Malignant Fallopian Tube Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3032",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C7074",
                "name": "Serous Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor, metastatic",
                    "Metastatic Tumor",
                    "Neoplasm, metastatic",
                    "Metastatic"
                ],
                "nci_thesaurus_concept_id": "C3261",
                "name": "Metastatic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C8511",
                "name": "Refractory Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C120186"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C170728",
                "name": "Metastatic Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C9335"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150526",
                "name": "Recurrent Malignant Female Reproductive System Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C177724",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156711",
                "name": "Malignant Peritoneal and Retroperitoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7337"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Female reprod. system cancer, NOS",
                    "Malignant Neoplasm of Female Reproductive System",
                    "Gynecologic Cancer",
                    "Malignant Tumor of Female Reproductive System",
                    "Female Reproductive Cancer",
                    "Malignant Tumor of the Female Reproductive System",
                    "Malignant Neoplasm of the Female Reproductive System",
                    "Malignant Female Reproductive System Tumor",
                    "Malignant Gynecologic Neoplasm",
                    "Malignant Gynecologic Tumor",
                    "Female reproductive system cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C4913",
                "name": "Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3053",
                    "C36076"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of the Breast",
                    "Adenocarcinoma of Breast",
                    "Mammary adenocarcinoma"
                ],
                "nci_thesaurus_concept_id": "C5214",
                "name": "Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C4872"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Primary Peritoneal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C152046",
                "name": "Refractory Primary Peritoneal Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8511",
                    "C40022"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Uterine Corpus Endomential Carcinoma",
                    "CARCINOMA, ENDOMETRIAL, MALIGNANT",
                    "Carcinoma of the Endometrium",
                    "Endometrial Carcinoma",
                    "Carcinoma of Endometrium",
                    "UCEC"
                ],
                "nci_thesaurus_concept_id": "C7558",
                "name": "Endometrial Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C61574",
                    "C181162",
                    "C27815"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Uterine Corpus Carcinoma or Carcinosarcoma by AJCC v8 Stage",
                    "Tumor Stage (Pathological)"
                ],
                "nci_thesaurus_concept_id": "C139801",
                "name": "Uterine Corpus Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C61574"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C40099",
                "name": "Fallopian Tube Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C6265",
                    "C40102",
                    "C40101"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of the Lung",
                    "Malignant Tumor of Lung",
                    "Malignant Tumor of the Lung",
                    "Malignant Lung Tumor",
                    "Malignant Neoplasm of Lung"
                ],
                "nci_thesaurus_concept_id": "C7377",
                "name": "Malignant Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3576",
                    "C4571",
                    "C3200"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C53553",
                "name": "Breast Carcinoma by Gene Expression Profile",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of the Fallopian Tube",
                    "Adenocarcinoma of Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C6265",
                "name": "Fallopian Tube Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2852",
                    "C3867"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Female Reproductive System Cancer"
                ],
                "nci_thesaurus_concept_id": "C152048",
                "name": "Refractory Female Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C8511",
                    "C150527"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150091",
                "name": "Refractory Ovarian Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C152048",
                    "C4908"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C40101",
                "name": "Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7074",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelial Neoplasm of Ovary",
                    "Ovarian Surface Epithelial-Stromal Tumor",
                    "Ovarian Surface-Epithelial Stromal Neoplasm",
                    "Epithelial Tumor of Ovary",
                    "Epithelial Neoplasm of the Ovary",
                    "Epithelial Tumor of the Ovary"
                ],
                "nci_thesaurus_concept_id": "C4381",
                "name": "Ovarian Epithelial Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709",
                    "C4984"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C176862",
                "name": "Metastatic Malignant Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C3576"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor_Morphology",
                    "Tumor Morphology"
                ],
                "nci_thesaurus_concept_id": "C4741",
                "name": "Neoplasm by Morphology",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Cancer",
                    "resistant cancer",
                    "clinical resistance"
                ],
                "nci_thesaurus_concept_id": "C120186",
                "name": "Refractory Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C7628"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of Fallopian Tube",
                    "Fallopian Tube Carcinoma",
                    "Cancer of the Fallopian Tube",
                    "Carcinoma of the Fallopian Tube",
                    "Cancer of Fallopian Tube"
                ],
                "nci_thesaurus_concept_id": "C3867",
                "name": "Fallopian Tube Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181162",
                    "C7201",
                    "C7480"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C40025",
                "name": "Malignant Ovarian Serous Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C40026",
                    "C8431"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Refractory Fallopian Tube Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C152047",
                "name": "Refractory Fallopian Tube Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3867",
                    "C152048"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Genitourinary System Malignant Neoplasm",
                    "Metastatic Malignant Genitourinary System Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C157774",
                "name": "Metastatic Genitourinary Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C36263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal Disease"
                ],
                "nci_thesaurus_concept_id": "C26848",
                "name": "Peritoneal Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27664"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genitourinary System Cancer",
                    "Genitourinary Cancer",
                    "Malignant Genitourinary Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C156484",
                "name": "Malignant Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C156482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C4571",
                "name": "Malignant Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3355",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Ovarian Surface Epithelial-Stromal Tumor",
                    "Ovarian stromal cancer",
                    "Malignant Ovarian Surface Epithelial-Stromal Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C40026",
                "name": "Malignant Ovarian Epithelial Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7431",
                    "C4381"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm of the Uterine Corpus",
                    "Uterine Body Tumor",
                    "Neoplasm of the Uterine Body",
                    "Uterine Corpus Tumor",
                    "Tumor of Uterine Corpus",
                    "Uterine Body Neoplasm",
                    "Neoplasm of the Corpus Uteri",
                    "Tumor of the Corpus Uteri",
                    "Neoplasm of Corpus Uteri",
                    "Neoplasm of Uterine Corpus",
                    "Neoplasm of Body of Uterus",
                    "Neoplasm of the Body of Uterus",
                    "Corpus Uteri Tumor",
                    "Neoplasm of Uterine Body",
                    "Corpus Uteri Neoplasm",
                    "Tumor of the Uterine Body",
                    "Tumor of Uterine Body",
                    "Tumor of Corpus Uteri",
                    "Tumor of the Uterine Corpus"
                ],
                "nci_thesaurus_concept_id": "C6300",
                "name": "Uterine Corpus Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3435"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Estrogen Receptor and Progesterone Receptor Negative Breast Carcinoma",
                    "Hormone Receptor Negative Breast Adenocarcinoma",
                    "Hormone Receptor-Negative Breast Carcinoma",
                    "ER and PR Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C165743",
                "name": "Hormone Receptor Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube Disease"
                ],
                "nci_thesaurus_concept_id": "C26771",
                "name": "Fallopian Tube Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Peritoneal Cancer",
                    "Cancer of Peritoneum",
                    "Cancer of the Peritoneum",
                    "Peritoneal Cavity Cancer"
                ],
                "nci_thesaurus_concept_id": "C3538",
                "name": "Malignant Peritoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156711",
                    "C3322"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Neoplasm",
                    "Tumor of the Ovary",
                    "Neoplasm of Ovary",
                    "Tumor of Ovary",
                    "Neoplasm of the Ovary",
                    "Ovarian Tumors"
                ],
                "nci_thesaurus_concept_id": "C4984",
                "name": "Ovarian Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26841",
                    "C3053"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Urogenital Disease",
                    "Genitourinary Disorder"
                ],
                "nci_thesaurus_concept_id": "C156660",
                "name": "Genitourinary System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C169021",
                "name": "Platinum-Resistant Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C150527"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Disease"
                ],
                "nci_thesaurus_concept_id": "C26841",
                "name": "Ovarian Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Respiratory Tract Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3355",
                "name": "Respiratory System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26871",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36310",
                "name": "Secondary Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C4968"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Relapsed Cancer",
                    "Relapsed Carcinoma",
                    "Recurrent Cancer"
                ],
                "nci_thesaurus_concept_id": "C7619",
                "name": "Recurrent Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4813",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3263",
                "name": "Neoplasm by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3262"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Cancer"
                ],
                "nci_thesaurus_concept_id": "C36263",
                "name": "Metastatic Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4968",
                    "C3261"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3504",
                "name": "Endometrial Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26907"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C65151",
                "name": "Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Respiratory System",
                    "Respiratory Disorder",
                    "Unspecified Respiratory Problem"
                ],
                "nci_thesaurus_concept_id": "C26871",
                "name": "Respiratory System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Epithelial Neoplasm",
                    "Epithelial tumor, malignant",
                    "Carcinoma",
                    "Carcinoma, NOS",
                    "Malignant Epithelioma",
                    "Epithelioma Malignant",
                    "CARCINOMA, MALIGNANT",
                    "Malignant Epithelial Tumor",
                    "Epithelial Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C2916",
                "name": "Other Carcinoma",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9305",
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disease by Site"
                ],
                "nci_thesaurus_concept_id": "C27551",
                "name": "Disorder by Site",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2991"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Fallopian Tube Serous Tumor"
                ],
                "nci_thesaurus_concept_id": "C40102",
                "name": "Fallopian Tube Serous Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7074",
                    "C3032"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "PPC",
                    "Primary Peritoneal Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C40022",
                "name": "Primary Peritoneal Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C3538"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C36076",
                "name": "Malignant Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156484",
                    "C3674"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C150527",
                "name": "Refractory Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C120186",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, NOS",
                    "ADENOCARCINOMA, MALIGNANT"
                ],
                "nci_thesaurus_concept_id": "C2852",
                "name": "Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C7132"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Uterine Tumor",
                    "Uterine Neoplasms",
                    "Tumor of Uterus",
                    "Tumor of the Uterus",
                    "Neoplasm of the Uterus",
                    "Neoplasm of Uterus"
                ],
                "nci_thesaurus_concept_id": "C3435",
                "name": "Uterine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3053",
                    "C26907"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Breast Disease",
                    "Breast Diseases"
                ],
                "nci_thesaurus_concept_id": "C26709",
                "name": "Breast Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27551"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Genital Disorders",
                    "Reproductive System Disease",
                    "Disorder of Reproductive System"
                ],
                "nci_thesaurus_concept_id": "C4875",
                "name": "Reproductive System Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Urogenital Carcinoma",
                    "Metastatic Genitourinary Cancer",
                    "Metastatic Genitourinary Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C146893",
                "name": "Metastatic Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C164141",
                    "C3482",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Non-Small Cell Carcinoma of Lung",
                    "Lung Non-Small Cell Carcinoma",
                    "Non-Small Cell Cancer of Lung",
                    "NSCLC - Non-Small Cell Lung Cancer",
                    "Non-Small Cell Carcinoma of the Lung",
                    "Non-Small Cell Lung Carcinoma",
                    "Non Small Cell Lung Cancer NOS",
                    "Non-Small Cell Cancer of the Lung",
                    "NSCLC",
                    "Non-small cell lung cancer, NOS"
                ],
                "nci_thesaurus_concept_id": "C2926",
                "name": "Non-Small Cell Lung Cancer",
                "type": [
                    "maintype",
                    "subtype"
                ],
                "parents": [
                    "C4878",
                    "C65151"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C40023",
                "name": "Primary Peritoneal Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C170733",
                    "C40101"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Infrequent Tumor"
                ],
                "nci_thesaurus_concept_id": "C7201",
                "name": "Infrequent Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Lung cancer, NOS",
                    "Lung Carcinoma",
                    "Cancer of Lung",
                    "Carcinoma of the Lung",
                    "Cancer of the Lung",
                    "Lung Cancer (all types)",
                    "Carcinoma of Lung"
                ],
                "nci_thesaurus_concept_id": "C4878",
                "name": "Lung Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C2916",
                    "C7377"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C167260",
                "name": "Advanced Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C176859",
                    "C162254"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C181162",
                "name": "Female Reproductive System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4913",
                    "C164141"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164141",
                "name": "Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C2916",
                    "C156484"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Uterine Disease"
                ],
                "nci_thesaurus_concept_id": "C26907",
                "name": "Uterine Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrence",
                    "Recurrent Cancer",
                    "Recurrent Malignant Tumor"
                ],
                "nci_thesaurus_concept_id": "C4813",
                "name": "Recurrent Malignant Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4798",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Uterine Body Neoplasm",
                    "Malignant Corpus Uteri Tumor",
                    "Malignant Neoplasm of Uterine Body",
                    "Malignant Tumor of the Uterine Body",
                    "Malignant Uterine Corpus Tumor",
                    "Malignant Neoplasm of the Uterine Body",
                    "Malignant Uterine Body Tumor",
                    "Malignant Corpus Uteri Neoplasm",
                    "Malignant Tumor of Uterine Body"
                ],
                "nci_thesaurus_concept_id": "C3556",
                "name": "Malignant Uterine Corpus Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3552",
                    "C6300"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165537",
                "name": "Metastatic Non-Small Cell Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C65151"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Neoplasm of Ovary",
                    "Ovarian Cancer",
                    "Cancer of the Ovary",
                    "Malignant Tumor of Ovary",
                    "Malignant Tumor of the Ovary",
                    "Malignant Neoplasm of the Ovary",
                    "Cancer of Ovary",
                    "Ovarian cancer, NOS",
                    "Malignant Ovarian Tumor"
                ],
                "nci_thesaurus_concept_id": "C7431",
                "name": "Malignant Ovarian Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4984",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Uterine Corpus Carcinoma",
                    "Recurrent Uterine Corpus Cancer",
                    "Recurrent Corpus Uteri Cancer"
                ],
                "nci_thesaurus_concept_id": "C9072",
                "name": "Recurrent Uterine (Including Endometrial) Cancer",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C61574",
                    "C150526"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Thorax",
                    "Neoplasm of Thorax",
                    "Thoracic Tumor",
                    "Neoplasm of the Thorax",
                    "Tumor of Thorax"
                ],
                "nci_thesaurus_concept_id": "C3406",
                "name": "Thoracic Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3263",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C156482",
                "name": "Genitourinary System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C156660",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor of the Breast",
                    "Tumor of Breast",
                    "Breast Tumor",
                    "Neoplasm of the Breast",
                    "Neoplasm of Breast"
                ],
                "nci_thesaurus_concept_id": "C2910",
                "name": "Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26709",
                    "C3263"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Recurrent Female Reproductive System Cancer"
                ],
                "nci_thesaurus_concept_id": "C7620",
                "name": "Recurrent Female Reproductive System Carcinoma",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7619",
                    "C150526"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C164143",
                "name": "Advanced Genitourinary System Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153171",
                    "C146893",
                    "C176859"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Glandular Cell Epithelium Neoplasm",
                    "Glandular Cell Epithelial Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C7132",
                "name": "Glandular Cell Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3709"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Neoplasm Recurrence",
                    "Recurrence",
                    "Recurrent Tumor",
                    "Recurrent"
                ],
                "nci_thesaurus_concept_id": "C4798",
                "name": "Recurrent Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Uterine Cancer",
                    "Uterine cancer, NOS",
                    "Cancer of the Uterus",
                    "Malignant Neoplasm of Uterus",
                    "Malignant Uterine Tumor",
                    "Malignant Tumor of the Uterus",
                    "Malignant Neoplasm of the Uterus",
                    "Malignant Tumor of Uterus",
                    "Cancer of Uterus"
                ],
                "nci_thesaurus_concept_id": "C3552",
                "name": "Malignant Uterine Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3435",
                    "C4913"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C165698",
                "name": "Metastatic Breast Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C153238",
                    "C4124",
                    "C5214"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Malignant Tumor of Breast",
                    "Malignant Breast Tumor",
                    "Malignant Tumor of the Breast",
                    "Malignant Neoplasm of Breast",
                    "Malignant Neoplasm of the Breast"
                ],
                "nci_thesaurus_concept_id": "C9335",
                "name": "Malignant Breast Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C9305",
                    "C2910"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C3482",
                "name": "Metastatic Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36263",
                    "C36310"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C177724",
                "name": "Recurrent Malignant Genitourinary System Neoplasm",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C156484",
                    "C4813"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C172450",
                "name": "Advanced Uterine Corpus Cancer",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C61574",
                    "C167260"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Female Reproductive System Tumor",
                    "Tumor of the Female Reproductive System",
                    "Tumor of Female Reproductive System",
                    "Neoplasm of Female Reproductive System",
                    "Neoplasm of the Female Reproductive System",
                    "Gynecologic Tumor",
                    "Gynecologic Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C3053",
                "name": "Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3674",
                    "C27020"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Metastatic Hormone Receptor Negative Breast Carcinoma"
                ],
                "nci_thesaurus_concept_id": "C190677",
                "name": "Metastatic Hormone Receptor-Negative Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C165698",
                    "C165743"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C153238",
                "name": "Metastatic Breast Carcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4872",
                    "C170728",
                    "C3482"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Epithelioma",
                    "Epithelioma, malignant",
                    "Epithelial Neoplasms, NOS"
                ],
                "nci_thesaurus_concept_id": "C3709",
                "name": "Epithelial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4741"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Tumor Stage (Pathological)"
                ],
                "nci_thesaurus_concept_id": "C136467",
                "name": "Lung Cancer by AJCC v8 Stage",
                "type": [
                    "stage"
                ],
                "parents": [
                    "C4878"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Serous Carcinoma",
                    "Serous carcinoma",
                    "Serous Adenocarcinoma of Ovary",
                    "Serous Carcinoma of the Ovary",
                    "Serous Adenocarcinoma of the Ovary",
                    "Serous Carcinoma of Ovary"
                ],
                "nci_thesaurus_concept_id": "C7550",
                "name": "Ovarian Serous Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7700",
                    "C40025",
                    "C40101"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Ovarian Carcinoma",
                    "Ovarian Epithelial Cancer",
                    "Epithelial Ovarian Cancer",
                    "Carcinoma of Ovary",
                    "Carcinoma of the Ovary"
                ],
                "nci_thesaurus_concept_id": "C4908",
                "name": "Ovarian Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C181162",
                    "C40026"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Serous Tumor of the Ovary",
                    "Serous Tumor of Ovary",
                    "Serous Neoplasm of Ovary",
                    "Serous Neoplasm of the Ovary",
                    "Ovarian Serous Neoplasm"
                ],
                "nci_thesaurus_concept_id": "C8431",
                "name": "Ovarian Serous Tumor",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7074",
                    "C4381"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C3322",
                "name": "Peritoneal Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7337",
                    "C26848"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Carcinoma of the Breast",
                    "Cancer of Breast",
                    "Carcinoma of Breast",
                    "Breast cancer, NOS",
                    "Mammary Carcinoma",
                    "Breast Carcinoma",
                    "Cancer of the Breast"
                ],
                "nci_thesaurus_concept_id": "C4872",
                "name": "Breast Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C9335",
                    "C2916"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Endometrial Tumor",
                    "Tumor of the Endometrium",
                    "Endometrium Neoplasm",
                    "Endometrium Tumor",
                    "Neoplasm of Endometrium",
                    "Neoplasm of the Endometrium",
                    "Tumor of Endometrium"
                ],
                "nci_thesaurus_concept_id": "C3012",
                "name": "Endometrial Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3504",
                    "C6300"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Lung Tumor",
                    "Neoplasm of the Lung",
                    "Tumor of the Lung",
                    "Tumor of Lung",
                    "Neoplasm of Lung",
                    "Lung Neoplasms"
                ],
                "nci_thesaurus_concept_id": "C3200",
                "name": "Lung Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3355",
                    "C3198",
                    "C3406"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Tumor",
                    "Tumor, secondary",
                    "Neoplasm, secondary"
                ],
                "nci_thesaurus_concept_id": "C36255",
                "name": "Secondary Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C7062"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Cancer of the Corpus Uteri",
                    "Corpus Uteri Cancer",
                    "Uterine Corpus Cancer"
                ],
                "nci_thesaurus_concept_id": "C61574",
                "name": "Uterine (Including Endometrial) Cancer",
                "type": [
                    "maintype"
                ],
                "parents": [
                    "C3556"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [],
                "nci_thesaurus_concept_id": "C162254",
                "name": "Metastatic Malignant Female Reproductive System Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4913",
                    "C157774"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma, metastatic, NOS"
                ],
                "nci_thesaurus_concept_id": "C4124",
                "name": "Metastatic Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C3482",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Disorder of Lung",
                    "Pulmonary Disorders",
                    "Pulmonary Disorder",
                    "Lung Disorders",
                    "Pulmonary Diseases",
                    "Pulmonary Disease"
                ],
                "nci_thesaurus_concept_id": "C3198",
                "name": "Lung Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C26871",
                    "C35742"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Adenocarcinoma of the Ovary",
                    "Adenocarcinoma of Ovary"
                ],
                "nci_thesaurus_concept_id": "C7700",
                "name": "Ovarian Adenocarcinoma",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C4908",
                    "C2852"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Secondary Cancer",
                    "Secondary Malignancy"
                ],
                "nci_thesaurus_concept_id": "C4968",
                "name": "Secondary Malignant Neoplasm",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C36255",
                    "C9305"
                ]
            },
            {
                "inclusion_indicator": "TREE",
                "is_lead_disease": false,
                "synonyms": [
                    "Thoracic Disease"
                ],
                "nci_thesaurus_concept_id": "C35742",
                "name": "Thoracic Disorder",
                "type": [
                    "subtype"
                ],
                "parents": [
                    "C27669"
                ]
            }
        ],
        "_primary_purpose_sort_order": 0,
        "protocol_id": "MORAb-202-G000-201",
        "active_sites_count": 8,
        "lead_org_cancer_center": null,
        "arms": [
            {
                "interventions": [
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Cancer-targeted Antibody Drug Conjugate",
                            "Antineoplastic Antibody-drug Conjugate",
                            "Drug-conjugated Antibody",
                            "Antineoplastic ADC"
                        ],
                        "nci_thesaurus_concept_id": "C129823",
                        "name": "Antineoplastic Antibody-Drug Conjugate",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C129821"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Biotherapeutic",
                            "Antineoplastic Biological",
                            "Anti-cancer Biological Agent",
                            "Anticancer Biological"
                        ],
                        "nci_thesaurus_concept_id": "C129821",
                        "name": "Antineoplastic Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C274",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunotherapy Agent",
                            "Biological Response Modifier",
                            "Immune Modulators",
                            "Immune Regulators",
                            "Immunotherapeutic Agent",
                            "Biomodulators",
                            "Immune Mediators",
                            "BRM",
                            "Immunomodulatory Agent",
                            "Immunomodulating Agent",
                            "Immunomodulators",
                            "Immunopotentiators"
                        ],
                        "nci_thesaurus_concept_id": "C308",
                        "name": "Immunotherapy",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TRIAL",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C173946",
                        "name": "Farletuzumab Ecteribulin",
                        "description": null,
                        "type": "Drug",
                        "category": "agent",
                        "parents": [
                            "C129823",
                            "C1512"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Agent",
                            "Drug",
                            "Pharmaceutical Agent",
                            "Pharmacologic Agent",
                            "Drug Substance",
                            "Pharmacological Substance",
                            "Pharmaceuticals"
                        ],
                        "nci_thesaurus_concept_id": "C1909",
                        "name": "Pharmacologic Substance",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1908"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1512",
                        "name": "Immunoconjugate",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C308",
                            "C307"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [],
                        "nci_thesaurus_concept_id": "C1908",
                        "name": "Drug, Food, Chemical or Biomedical Material",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": []
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Antineoplastic Drugs",
                            "Antiproliferative Agents",
                            "Antineoplastics",
                            "Cancer Drug",
                            "Tumor-Specific Treatment Agents",
                            "Anti-Cancer Agents",
                            "Anti-Tumor Drugs",
                            "Anti-Tumor Agents",
                            "Chemotherapeutic Agents, Neoplastic Disease",
                            "Antiproliferative Drugs"
                        ],
                        "nci_thesaurus_concept_id": "C274",
                        "name": "Antineoplastic Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    },
                    {
                        "inclusion_indicator": "TREE",
                        "synonyms": [
                            "Immunologic, Immunochemical",
                            "Biological Products",
                            "Biologicals",
                            "Biologics",
                            "Biopharmaceuticals",
                            "Immunologics"
                        ],
                        "nci_thesaurus_concept_id": "C307",
                        "name": "Biological Agent",
                        "description": null,
                        "type": "Drug",
                        "category": "agent category",
                        "parents": [
                            "C1909"
                        ]
                    }
                ],
                "name": "Arm not specified",
                "description": null,
                "type": null
            },
            {
                "interventions": [],
                "name": "Dose Confirmation Part: Farletuzumab ecteribulin (25 mg/m^2)",
                "description": "Participants with EC and OC will receive farletuzumab ecteribulin at 25 milligram per meter square (mg/m^2) administered as an intravenous infusion, once every 3 weeks in a 21 days cycle or until intolerable toxicity, disease progression, or participant withdrawal for any reason.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Confirmation Part: Farletuzumab ecteribulin (33 mg/m^2)",
                "description": "Participants with EC and OC will receive farletuzumab ecteribulin at 33 mg/m^2 administered as an intravenous infusion, once every 3 weeks in a 21 days cycle or until intolerable toxicity, disease progression, or participant withdrawal for any reason.",
                "type": "EXPERIMENTAL"
            },
            {
                "interventions": [],
                "name": "Dose Escalation: Farletuzumab ecteribulin",
                "description": "Participants with selected tumor type will receive farletuzumab ecteribulin at a starting dose of 0.9, 1.2, 1.6 milligram per kilogram (mg/kg) administered as an intravenous infusion, once every 3 weeks in a 21 days cycle or until intolerable toxicity, disease progression, or participant withdrawal for any reason.",
                "type": "EXPERIMENTAL"
            }
        ],
        "study_model_code": null,
        "nci_id": "NCI-2020-06147",
        "why_study_stopped": null,
        "brief_summary": "The primary objectives of the study are: (1) in the dose-escalation part: to evaluate safety\r\n      and tolerability and to determine the recommended Phase 2 dose (RP2D) of farletuzumab\r\n      ecteribulin in participants with selected tumor types (ovarian cancer [OC], endometrial\r\n      cancer [EC], non-small cell lung carcinoma [NSCLC], triple-negative breast cancer [TNBC]),\r\n      and (2) in dose-confirmation part: to evaluate preliminary efficacy measured by objective\r\n      response rate (ORR) of farletuzumab ecteribulin in participants with OC and EC at selected\r\n      doses and to further evaluate the safety and tolerability of farletuzumab ecteribulin.",
        "brief_title": "A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FR\u03b1)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types",
        "status_history": [
            {
                "status_date": "2022-04-19T00:00:00.000003",
                "status": "ACTIVE"
            },
            {
                "status_date": "2021-10-19T00:00:00.000002",
                "status": "TEMPORARILY_CLOSED_TO_ACCRUAL"
            },
            {
                "status_date": "2020-08-06T00:00:00.000001",
                "status": "ACTIVE"
            },
            {
                "status_date": "2020-03-06T00:00:00",
                "status": "IN_REVIEW"
            }
        ],
        "study_population_description": null,
        "sampling_method_code": null,
        "minimum_target_accrual_number": 55,
        "prior_therapy": [],
        "_current_trial_status_sort_order": 0,
        "start_date": "2020-08-06",
        "record_verification_date": "2022-08-01",
        "ctep_id": null,
        "current_trial_status": "Active",
        "study_model_other_text": null,
        "masking": {
            "role_caregiver": null,
            "masking": null,
            "role_investigator": null,
            "role_outcome_assessor": null,
            "role_subject": null,
            "allocation_code": "Non-Randomized Trial"
        },
        "acronym": null,
        "nci_programs": [],
        "nci_funded": "Indirect",
        "anatomic_sites": [
            "Multiple"
        ],
        "ccr_id": null,
        "start_date_type_code": "ACTUAL",
        "principal_investigator": null,
        "study_source": "Industrial",
        "completion_date": "2025-03-31",
        "study_subtype_code": null,
        "study_protocol_type": "Interventional"
    }
]